Theresa Eagleson, HFS Director | https://hfs.illinois.gov/about/director.html
Theresa Eagleson, HFS Director | https://hfs.illinois.gov/about/director.html
Illinois Department of Healthcare and Family Services Drugs and Therapeutics Advisory Board met April 11.
Here is the agenda provided by the board:
I. Call to Order
II. Roll Call
III. Announcements
IV. Agenda and Conflict of Interest Review
V. Approval of the Minutes
VI. PDL Drug Appeals
a. Vraylar
b. Siklos
c. Carbaglu
VII. New Drug Appeals
a. None for this meeting
VIII. Drug Class Review- Jen Phillips, PharmD clinical review (with discussion and vote)
a. Adrenergic Combination Inhalers
b. Anticholinergic Inhalers
c. Beta Adrenergic Inhalers
d. Steroid Inhalers
IX. New Drug Initial Review-Jen Phillips, PharmD clinical review(with discussion and vote)
a. Casgevy
b. Daybue
c. Skyclarys
d. Xdemvy
e. Ogsiveo
X. Public Comments
XI. Future Agenda Preview -Sheri Dolan
• Class reviews 2024
XII. Provider Requested Reviews-Sheri Dolan
a. None for this meeting
XIII. Department Update-Jose Jimenez
XIV. Adjournment
https://hfs.illinois.gov/content/dam/soi/en/web/hfs/sitecollectiondocuments/bpasdt04112024agenda.pdf
Alerts Sign-up